CVS Group plc
26 February 2008
For Immediate release 26 February 2008
CVS Group plc
('CVS' or the 'Group')
Acquisition of 50th Practice
CVS, one of the UK's leading providers of veterinary services, is pleased to
announce the acquisition of Michael Gourley Veterinary Surgeons in Manchester.
This transaction marks the 50th acquisition by CVS, bringing the total number of
surgeries within the group to 140.
The practice acquired was formed in 1954 and employs nine vets across its
principal site in Ashton and five branches in the local area.
In the year ended 30 April 2007 the practice achieved EBITDA of approximately
£150,000 on turnover of £1.533m and had gross assets of £665,000.
Commenting on the acquisition, CVS Chief Executive Simon Innes said:
'We are delighted to welcome Michael Gourley and his team to CVS. Their
reputation for excellence in clinical care makes them an ideal partner for our
existing practitioners'.
Contacts:
CVS Group plc 01379 644 288
Simon Innes, Chief Executive
Paul Coxon, Finance Director
Buchanan Communications 020 7466 5000
Richard Oldworth
Suzanne Brocks
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.